Dellarex Biotec

Dombivli, India
Distributes high-quality pharmaceuticals for oncology, urology, and other specialties.

About Dellarex Biotec

Dellarex Biotec is a Healthcare company based in Dombivli (India). Distributes high-quality pharmaceuticals for oncology, urology, and other specialties. It operates on a B2B and B2C model. Its Indian entity Dellarex Biotec Private Limited reported revenue of β‚Ή29.19 Cr. Dellarex Biotec offers products and services including Oncology Pharmaceuticals, Urology Pharmaceuticals, Virology Pharmaceuticals, Ophthalmology Pharmaceuticals, and Nephrology Pharmaceuticals. Its focus areas include Pharmaceuticals, Distribution, Specialty Drugs and Medical Specialties.

Company details

Dellarex Biotec Is A Pharmaceutical Distribution Company Based In Mumbai, India, Offering Affordable, Effective Pharmaceuticals In Categories Like Oncology And Urology. They Focus On Innovative Programs For Healthcare Enhancement, Ensuring Prompt Delivery Across The Country. The Company Serves As A Preferred Partner For Top Pharma Brands, Handling Bulk Orders And Maintaining Strict Regulatory Compliance.

  • Headquarters Dombivli, India
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website dellarexbiotec.com
  • Legal Name Dellarex Biotec Private Limited
  • Date of Incorporation 19 Sep, 2016
  • Jurisdiction Thane, Maharashtra, India
Key Metrics
  • Annual Revenue
    ₹29.19 Cr

    FY 2025 · +34% YoY

  • Net Profit
    ₹33.6 Lakh

    FY 2025 · 1% margin

  • EBITDA
    ₹78.9 Lakh

    FY 2025 · 3% margin

Products & Services of Dellarex Biotec

Dellarex Biotec offers a comprehensive portfolio of products and services, including Oncology Pharmaceuticals, Urology Pharmaceuticals, Virology Pharmaceuticals, Ophthalmology Pharmaceuticals, and Nephrology Pharmaceuticals.

Oncology Pharmaceuticals
Pharmaceutical Distribution

Distribution of drugs for cancer treatment and care.

Urology Pharmaceuticals
Pharmaceutical Distribution

Supply of medications for urological conditions.

Virology Pharmaceuticals
Pharmaceutical Distribution

Provision of antiviral drugs for viral infections.

Ophthalmology Pharmaceuticals
Pharmaceutical Distribution

Distribution of eye care medications and products.

Nephrology Pharmaceuticals
Pharmaceutical Distribution

Supply of drugs for kidney-related disorders.

Board of directors of Dellarex Biotec Private Limited (Dellarex Biotec)

Dellarex Biotec Private Limited is the primary company behind Dellarex Biotec. The board of Dellarex Biotec Private Limited currently have 2 directors; the longest-serving is Reji Cyriac, appointed in 2016.

DirectorDesignationAppointedTenureEntity
Reji Cyriac
DIN 07604987
Director19 Sep 201610 yrs 1 moDellarex Biotec Private Limited
Sija Reji Cyriac
DIN 07604988
Director19 Sep 201610 yrs 1 moDellarex Biotec Private Limited

Financials of Dellarex Biotec

Figures of Dellarex Biotec Private Limited, the primary company behind Dellarex Biotec, for FY 2025. Revenue was ₹29.19 Cr (+34% year on year). Net profit was ₹33.6 Lakh (1% margin). EBITDA was ₹78.9 Lakh (3% margin). Revenue has grown at a compounded annual rate of +8% over three years and +25% over five years.

  • ₹29.19 CrRevenue · FY 2025 · +34% YoY
  • ₹33.6 LakhNet profit · 1% margin
  • ₹78.9 LakhEBITDA · 3% margin
  • ₹30 LakhPaid-up capital
  • +8%Revenue CAGR, 3 years
  • +25%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Dellarex Biotec Private Limited are on its company page.

Premium access

Detailed financial statements for Dellarex Biotec

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Dellarex Biotec

Dellarex Biotec is headquartered in Dombivli, India. It is registered at Dombivli, Maharashtra, India.

The primary company behind Dellarex Biotec, Dellarex Biotec Private Limited, reported revenue of β‚Ή29.19 Cr for FY 2025, up 34% year on year.

Dellarex Biotec Is A Pharmaceutical Distribution Company Based In Mumbai, India, Offering Affordable, Effective Pharmaceuticals In Categories Like Oncology And Urology. They Focus On Innovative Programs For Healthcare Enhancement, Ensuring Prompt Delivery Across The Country. The Company Serves As A Preferred Partner For Top Pharma Brands, Handling Bulk Orders And Maintaining Strict Regulatory Compliance.

Dellarex Biotec offers Oncology Pharmaceuticals, Urology Pharmaceuticals, Virology Pharmaceuticals, Ophthalmology Pharmaceuticals, and Nephrology Pharmaceuticals.

Dellarex Biotec operates through Dellarex Biotec Private Limited.

The legal entities of Dellarex Biotec currently have 2 directors, including Reji Cyriac, Sija Reji Cyriac.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available